Drug profile · INN
amprenavir
AGENERASE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
amprenavir (AGENERASE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN amprenavir
Brand AGENERASE
Route ORAL
Formulation CAPSULE
ATC code J05AE05
Frequently asked questions
What is amprenavir?
amprenavir (AGENERASE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for amprenavir?
AGENERASE is a marketed brand name for amprenavir. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amprenavir?
amprenavir has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.